Hickory, NC, United States of America

Sreerama Murthy Mallipeddi

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Exela Pharma Sciences, LLC. Active years: 2016-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sreerama Murthy Mallipeddi. Retrieved from https://idiyas.com/inventor/sreerama-murthy-mallipeddi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2016-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Sreerama Murthy Mallipeddi: Innovator in Pharmaceutical Compositions

Introduction

Sreerama Murthy Mallipeddi is a notable inventor based in Hickory, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for medical use. With a total of 2 patents to his name, his work has the potential to impact patient care and treatment options.

Latest Patents

Mallipeddi's latest patents focus on Ganciclovir compositions and related methods. These patents disclose Ganciclovir formulations that are ready-to-use, substantially particulate free, and stable upon storage. Additionally, the patents provide methods of manufacture and administration of such compositions, showcasing his commitment to improving pharmaceutical formulations.

Career Highlights

Sreerama Murthy Mallipeddi is currently associated with Exela Pharma Sciences, LLC, where he continues to innovate in the pharmaceutical sector. His work is characterized by a dedication to enhancing the efficacy and safety of drug formulations.

Collaborations

Some of his notable coworkers include Jonathan E Sterling and Phanesh B Koneru, who contribute to the collaborative environment that fosters innovation at Exela Pharma Sciences.

Conclusion

Sreerama Murthy Mallipeddi's contributions to pharmaceutical innovations, particularly in Ganciclovir formulations, highlight his role as a key inventor in the industry. His work not only advances medical science but also enhances treatment options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…